Form 8-K - Current report:
SEC Accession No. 0001564590-20-017098
Filing Date
2020-04-16
Accepted
2020-04-16 17:04:19
Documents
19
Period of Report
2020-04-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K idxx-8k_20200410.htm   iXBRL 8-K 91652
2 EX-10.2 idxx-ex102_6.htm EX-10.2 62273
3 EX-10.3 idxx-ex103_7.htm EX-10.3 315318
4 EX-10.4 idxx-ex104_8.htm EX-10.4 80107
5 EX-10.5 idxx-ex105_9.htm EX-10.5 82937
6 EX-10.6 idxx-ex106_10.htm EX-10.6 1225007
7 GRAPHIC gevf14l3abh5000001.jpg GRAPHIC 3350
8 GRAPHIC gzubzp42oeeb000001.jpg GRAPHIC 2130
  Complete submission text file 0001564590-20-017098.txt   2269978

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA idxx-20200410.xsd EX-101.SCH 5764
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE idxx-20200410_lab.xml EX-101.LAB 18708
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idxx-20200410_pre.xml EX-101.PRE 11164
16 EXTRACTED XBRL INSTANCE DOCUMENT idxx-8k_20200410_htm.xml XML 3420
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 20797009
SIC: 2835 In Vitro & In Vivo Diagnostic Substances